Lars Wallentin

Lars Wallentin (born 1943) is a Swedish physician and cardiologist. In 1998 he was the first recipient of the Nordic Medical Prize, the second largest medical award in the Nordic countries. He was elected as a member of the Royal Swedish Academy of Sciences in 2007. He has been described by the ''European Heart Journal'' as "an international superstar cardiologist."

He holds a doctorate in medicine from Linköping University in 1976 and is a full professor of cardiology at Uppsala University. He is one of the world's leading experts on unstable coronary artery disease, and one of the most highly cited cardiologists overall. Provided by Wikipedia
Showing 1 - 3 results of 3 for search 'Lars Wallentin', query time: 0.01s Refine Results
  1. 1
    Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation

    Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation by Julia Aulin, Karl Sjölin, Johan Lindbäck, Alexander P. Benz, John W. Eikelboom, Kim Kultima, Jonas Oldgren, Lars Wallentin, Joachim Burman

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study.

    Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study. by Lars Wallentin, Niclas Eriksson, Maciej Olszowka, Tanja B Grammer, Emil Hagström, Claes Held, Marcus E Kleber, Wolfgang Koenig, Winfried März, Ralph A H Stewart, Harvey D White, Mikael Åberg, Agneta Siegbahn

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient‐Level Meta‐Analysis From COMBINE AF

    Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient‐Level Meta‐Analysis From COMBINE AF by Linda S. Johnson, Alexander P. Benz, Ashkan Shoamanesh, John W. Eikelboom, Michael Ezekowitz, Robert P. Giugliano, Lars Wallentin, Christian T. Ruff, Renato D. Lopes, Sanjit Jolly, Richard Whitlock, Christopher B. Granger, Stuart Connolly, Jeffrey S. Healey

    Published 2024-09-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: